Literature DB >> 10733519

Human natural killer T cells acquire a memory-activated phenotype before birth.

H J van Der Vliet1, N Nishi, T D de Gruijl, B M von Blomberg, A J van den Eertwegh, H M Pinedo, G Giaccone, R J Scheper.   

Abstract

Natural killer T (NKT) cells have recently been shown to play an important role in the rejection of malignant tumors and in the regulation of autoimmune diseases. Potent antitumor effects of the marine sponge-derived NKT cell ligand KRN7000 were observed in mice. Therefore, the elucidation of the natural ligand of NKT cells, which is currently still unknown, might have important clinical consequences for the treatment of cancer and autoimmune diseases. Analysis of cord blood mononuclear cells from healthy term infants demonstrated that in sharp contrast with the vast majority of cord blood lymphocytes, human NKT cells have already acquired a memory-activated phenotype before birth. This observation indicates that NKT cells encounter a natural ligand during fetal life and that this ligand is unlikely to be of microbial origin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733519

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell.

Authors:  Joyce Rauch; Jenny Gumperz; Cheryl Robinson; Markus Sköld; Chris Roy; David C Young; Michel Lafleur; D Branch Moody; Michael B Brenner; Catherine E Costello; Samuel M Behar
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

2.  IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

Authors:  Ho Ngai; Gengwen Tian; Amy N Courtney; Soodeh B Ravari; Linjie Guo; Bin Liu; Jingling Jin; Elise T Shen; Erica J Di Pierro; Leonid S Metelitsa
Journal:  J Immunol       Date:  2018-08-15       Impact factor: 5.422

Review 3.  Donor Unrestricted T Cells: A Shared Human T Cell Response.

Authors:  Ildiko Van Rhijn; D Branch Moody
Journal:  J Immunol       Date:  2015-09-01       Impact factor: 5.422

Review 4.  In utero development of memory T cells.

Authors:  Dania Zhivaki; Richard Lo-Man
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

5.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

6.  Natural killer T cells constitutively expressing the interleukin-2 receptor α chain early in life are primed to respond to lower antigenic stimulation.

Authors:  Mihoko Ladd; Ashish Sharma; Qing Huang; Adele Y Wang; Lixin Xu; Indira Genowati; Megan K Levings; Pascal M Lavoie
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

7.  Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7.

Authors:  Johan K Sandberg; Cheryl A Stoddart; Fabienne Brilot; Kimberly A Jordan; Douglas F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 8.  How do natural killer T cells help B cells?

Authors:  Mark L Lang
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

9.  Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.

Authors:  Akira Iizuka; Yoshinori Ikarashi; Mitsuzi Yoshida; Yuji Heike; Kazuyoshi Takeda; Gary Quinn; Hiro Wakasugi; Masanobu Kitagawa; Yoichi Takaue
Journal:  Immunology       Date:  2007-11-14       Impact factor: 7.397

10.  Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.

Authors:  Sunil K Joshi; Gillian A Lang; Jason L Larabee; T Scott Devera; Lindsay M Aye; Hemangi B Shah; Jimmy D Ballard; Mark L Lang
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.